Stay updated with breaking news from Ryan Stump. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The introduction of synthetic nicotine alternatives like 6-methyl nicotine in vapes is raising concerns due to their potential higher potency and addictive nature compared to traditional nicotine. The FDA and researchers are investigating these compounds, but current data is insufficient. Regulatory gaps allow these products to be marketed without FDA authorization, posing risks to consumers.
Charlie’s Holdings, Inc. (OTCMKTS:CHUC – Get Rating) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 1,100 shares, a decrease of 84.5% from the April 30th total of 7,100 shares. Based on an average daily volume of 214,800 shares, the short-interest ratio is presently 0.0 days. […]
Charlie’s Holdings, Inc. (OTCMKTS:CHUC – Get Rating) saw a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 1,100 shares, a decrease of 84.5% from the April 30th total of 7,100 shares. Based on an average daily trading volume, of 214,800 shares, the short-interest ratio […]
Charlie’s (OTCMKTS:CHUC – Get Rating) is one of 59 public companies in the “Medicinals & botanicals” industry, but how does it compare to its peers? We will compare Charlie’s to related companies based on the strength of its institutional ownership, dividends, profitability, risk, earnings, analyst recommendations and valuation. Profitability This table compares Charlie’s and its […]
Charlie’s (OTCMKTS:CHUC – Get Rating) is one of 59 public companies in the “Medicinals & botanicals” industry, but how does it contrast to its rivals? We will compare Charlie’s to related companies based on the strength of its institutional ownership, profitability, earnings, valuation, analyst recommendations, dividends and risk. Profitability This table compares Charlie’s and its […]